Literature DB >> 1078639

The management of pulmonary metastases in children with osteogenic sarcoma with surgical resection combined with chemotherapy.

E J Beattie, N Martini, G Rosen.   

Abstract

This report concerns a consecutive group of 10 children with metastatic osteogenic sarcoma treated with combined surgery and chemotherapy. Eight of 10 patients had thoracotomy prior to chemotherapy, and 2 after an initial trial of chemotherapy. Sequential chemotherapy was given to all patients and consisted of vincristine, high-dose methotrexate with citrovorum factor rescue, cyclophosphamide, and Adriamycin. Chemotherapy was continuously recycled for 1 year. The encouraging results obtained with these 10 patients are demonstrated with emphasis on the value of aggressive multidisciplinary therapy in salvaging patients with advanced metastatic osteogenic sarcoma.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1078639     DOI: 10.1002/1097-0142(197503)35:3<618::aid-cncr2820350312>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  En bloc resection for osteogenic sarcoma.

Authors:  R C Marcove
Journal:  Bull N Y Acad Med       Date:  1979-09

2.  Hilar tuberculosis in a patient with osteosarcoma.

Authors:  B Cantwell; J J Fennelly; J Masterson; V Lynch
Journal:  Postgrad Med J       Date:  1981-08       Impact factor: 2.401

3.  [Diagnosis and treatment of bone tumors (author's transl)].

Authors:  H G Willert; A Enderle; G Fergenbauer
Journal:  Arch Orthop Unfallchir       Date:  1977-11-21

4.  Morphology of pulmonary metastases from osteosarcoma during chemotherapy.

Authors:  T Derstappen; A Roessner; K M Müller; E Grundmann
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

5.  The alteration in the pattern of pulmonary metastasis with adjuvant chemotherapy in osteosarcoma.

Authors:  H Yamaguchi; T Nojima; T Yagi; T Matsuno; T Sasaki; K Isu; Y Ubayama; S Yamawaki; M Gotch
Journal:  Int Orthop       Date:  1988       Impact factor: 3.075

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.